- Release Date: 03/09/21 11:41
- Summary: FDA grants Orphan Drug designation for Prader-Willi syndrome
- Price Sensitive: Yes
- Download Document 152.03KB
- Forums
- ASX - By Stock
- NEU
- Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.46 |
Change
0.210(1.04%) |
Mkt cap ! $2.585B |
Open | High | Low | Value | Volume |
$20.40 | $20.50 | $20.40 | $235.2K | 11.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 224 | $20.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.49 | 151 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 159 | 21.460 |
3 | 11 | 21.260 |
2 | 1098 | 21.240 |
1 | 867 | 21.030 |
2 | 569 | 21.020 |
Price($) | Vol. | No. |
---|---|---|
19.240 | 1596 | 7 |
19.430 | 169 | 1 |
19.540 | 679 | 1 |
19.650 | 7 | 2 |
19.800 | 6 | 1 |
Last trade - 10.09am 08/05/2024 (20 minute delay) ? |
|
|||||
Last
$20.38 |
  |
Change
0.210 ( 0.73 %) |
|||
Open | High | Low | Volume | ||
$20.45 | $20.50 | $20.26 | 3262 | ||
Last updated 10.29am 08/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online